Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-16 Sale | 2026-03-18 4:12 pm | Opus Genetics Inc. | IRD | SCHACHLE JOSEPH K Chief Operating Officer | 3,719 | $5.2501 | $19,525 | 300,781 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 4:11 pm | Opus Genetics Inc. | IRD | Zaremba Rabourn Amy Head of Fin. Quality Assurance | 2,816 | $5.245 | $14,770 | 190,312 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 4:10 pm | Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer | 24,438 | $5.2102 | $127,327 | 1,750,855 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 4:09 pm | Opus Genetics Inc. | IRD | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | 3,719 | $5.1213 | $19,046 | 516,775 (Direct) | View |
| 2025-12-29 Purchase | 2025-12-31 4:33 pm | Opus Genetics Inc. | IRD | Gallagher Cam Director | 164,000 | $1.9737 | $323,693 | 2,007,430 (Indirect Direct) | View |
| 2025-12-09 Sale | 2025-12-11 5:35 pm | Opus Genetics Inc. | IRD | Foundation Fighting Blindness Retinal Degeneration Fund Foundation Fighting Blindness Inc. See Remarks | 4,000,000 | $2.15 | $8,600,000 | 5,492,171 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-12 Tax Withholding | 2026-02-17 5:14 pm | N/A N/A | Opus Genetics Inc. | IRD | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | 5,313 | $3.39 | 520,494 (Direct) | View |
| 2026-01-22 Option Award | 2026-01-26 7:51 pm | N/A N/A | Opus Genetics Inc. | IRD | YERXA BENJAMIN R President | 400,000 | $0 | 719,005 (Direct) | View |
| 2026-01-22 Option Award | 2026-01-26 7:50 pm | N/A N/A | Opus Genetics Inc. | IRD | SCHACHLE JOSEPH K Chief Operating Officer | 250,000 | $0 | 304,500 (Direct) | View |
| 2026-01-22 Option Award | 2026-01-26 7:49 pm | N/A N/A | Opus Genetics Inc. | IRD | Zaremba Rabourn Amy Head of Fin. Quality Assurance | 86,500 | $0 | 193,128 (Direct) | View |
| 2026-01-22 Option Award | 2026-01-26 7:48 pm | N/A N/A | Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer | 483,639 | $0 | 1,775,293 (Direct) | View |
| 2026-01-22 Option Award | 2026-01-26 7:46 pm | N/A N/A | Opus Genetics Inc. | IRD | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | 400,000 | $0 | 525,807 (Direct) | View |
| 2026-01-22 Option Award | 2026-01-26 7:45 pm | N/A N/A | Opus Genetics Inc. | IRD | Gagnon Robert E. Chief Financial Officer | 400,000 | $0 | 600,000 (Direct) | View |
| 2026-01-18 Tax Withholding | 2026-01-21 4:05 pm | N/A N/A | Opus Genetics Inc. | IRD | Zaremba Rabourn Amy Head of Fin. Quality Assurance | 3,390 | $2.1 | 106,628 (Direct) | View |
| 2026-01-10 Tax Withholding | 2026-01-13 5:21 pm | N/A N/A | Opus Genetics Inc. | IRD | Zaremba Rabourn Amy Head of Fin. Quality Assurance | 3,950 | $1.93 | 110,018 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 4:13 pm | N/A N/A | Opus Genetics Inc. | IRD | Gallagher Cam Director | 67,000 | $0 | 2,074,430 (Direct) | View |
| 2026-01-01 Option Award | 2026-01-05 4:23 pm | N/A N/A | Opus Genetics Inc. | IRD | MANUSO JAMES S J Director | 31,188 | $0 | 292,951 (Direct) | View |
| 2026-01-01 Option Award | 2026-01-05 4:22 pm | N/A N/A | Opus Genetics Inc. | IRD | Graves Adrienne L Director | 23,643 | $0 | 103,147 (Direct) | View |
| 2026-01-01 Option Award | 2026-01-05 4:21 pm | N/A N/A | Opus Genetics Inc. | IRD | Bennett Jean Director | 21,127 | $0 | 234,652 (Direct) | View |
| 2026-01-01 Option Award | 2026-01-05 4:21 pm | N/A N/A | Opus Genetics Inc. | IRD | Ainsworth Sean Director | 42,507 | $0 | 297,325 (Direct) | View |
| 2025-12-31 Option Award | 2025-12-31 4:33 pm | N/A N/A | Opus Genetics Inc. | IRD | Gallagher Cam Director | 33,000 | $0 | 2,007,430 (Direct) | View |
| 2025-11-01 Tax Withholding(A) | 2025-11-05 4:06 pm | N/A N/A | Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer | 30,350 | $2.3 | 1,291,654 (Direct) | View |
| 2025-11-01 Tax Withholding | 2025-11-04 4:22 pm | N/A N/A | Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer | 30,350 | $2.3 | 1,291,654 (Direct) | View |
| 2025-10-22 Tax Withholding | 2025-10-24 4:16 pm | N/A N/A | Opus Genetics Inc. | IRD | YERXA BENJAMIN R President | 23,795 | $1.95 | 319,005 (Direct) | View |
| 2025-09-02 Option Award | 2025-09-11 6:03 pm | N/A 2035-09-01 | Opus Genetics Inc. | IRD | Gagnon Robert E. Chief Financial Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-08-25 Option Award | 2025-08-27 4:15 pm | N/A N/A | Opus Genetics Inc. | IRD | Gallagher Cam Director | 869,565 | $1.15 | 1,810,430 (Direct) | View |
| 2025-08-25 Option Award | 2025-08-27 4:13 pm | N/A N/A | Opus Genetics Inc. | IRD | Ainsworth Sean Director | 86,956 | $1.15 | 254,818 (Direct) | View |
| 2025-05-05 Conversion | 2025-05-06 6:05 pm | 2025-05-05 N/A | Opus Genetics Inc. | IRD | Foundation Fighting Blindness Retinal Degeneration Fund Foundation Fighting Blindness Inc. See Remarks 10% Owner | 6,934,346 | $0 | 9,492,171 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 5:09 pm | N/A 2035-04-29 | Opus Genetics Inc. | IRD | Rodgers Richard J Director | 159,096 | $0 | 398,247 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 5:08 pm | N/A 2035-04-29 | Opus Genetics Inc. | IRD | MANUSO JAMES S J Director | 159,096 | $0 | 341,355 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 5:06 pm | N/A 2035-04-29 | Opus Genetics Inc. | IRD | Graves Adrienne L Director | 159,096 | $0 | 159,096 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 5:05 pm | N/A 2035-04-29 | Opus Genetics Inc. | IRD | Gallagher Cam Director | 159,096 | $0 | 1,020,457 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 5:04 pm | N/A 2035-04-29 | Opus Genetics Inc. | IRD | Benton Susan Director | 159,096 | $0 | 299,119 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 5:03 pm | N/A 2035-04-29 | Opus Genetics Inc. | IRD | Bennett Jean Director | 159,096 | $0 | 293,117 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 5:02 pm | N/A 2035-04-29 | Opus Genetics Inc. | IRD | Ainsworth Sean Director | 159,096 | $0 | 247,454 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 4:10 pm | N/A 2030-03-24 | Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer | 392,157 | $0 | 1,714,161 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 4:08 pm | N/A 2030-03-24 | Opus Genetics Inc. | IRD | Gallagher Cam Director | 784,314 | $0 | 1,645,675 (Direct) | View |
| 2025-03-13 Option Award | 2025-03-17 8:56 pm | N/A 2035-03-12 | Opus Genetics Inc. | IRD | SCHACHLE JOSEPH K Chief Operating Officer | 52,500 | $0 | 107,000 (Direct) | View |
| 2025-03-13 Option Award | 2025-03-17 8:54 pm | N/A 2035-03-12 | Opus Genetics Inc. | IRD | Zaremba Rabourn Amy SVP of Finance | 39,500 | $0 | 153,468 (Direct) | View |
| 2025-03-13 Option Award | 2025-03-17 8:53 pm | N/A 2035-03-12 | Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer | 330,697 | $0 | 1,260,544 (Direct) | View |